Dr. Burke on a Study Investigating Obinutuzumab in Large B-Cell Lymphoma
December 5th 2016
John M. Burke, MD, discusses the GOYA study, a phase III study investigating obinutuzumab plus CHOP in patients with previously untreated diffuse large B-cell lymphoma. Burke discussed the study during the American Society of Hematology (ASH) Annual Meeting.